Angarus Therapeutics, Inc. — Form D
Angarus Therapeutics, Inc. of PORTOLA VALLEY, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-12-29. The offering totals $6.9M, of which $6.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-12-29
- Form: D
- Accession: 0001836891-20-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.9M
- Amount sold: $6.9M
- Investors: 34
- Date of first sale: 2020-12-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-384604
Issuer
- Name: Angarus Therapeutics, Inc.
- CIK: 0001836891
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 321 DEDALERA DR., PORTOLA VALLEY, CA, 94028
- Phone: 650-575-1702
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Chih-Ping Liu | Director | Portola Valley, CA |
| Nigel Ray | Director | Portola Valley, CA |
| Nigel Ray | Executive Officer | Portola Valley, CA |
| Peter Langecker | Director | Portola Valley, CA |
| Jean Liu | Director | Portola Valley, CA |
Other filings by this issuer (3)
More